The platform
Cardiac safety: testing drugs against populations of interest
How it works
1
Customize heart populations.
Apply treatments.
2
Extract biomarkers and data of interest from simulated ECGs
3
Compare trials
See population statistics
Access subject specific data
Key benefits
Define your compound with precision and design a dosing strategy without limitations, including off-label or supra-therapeutic scenarios.
Build virtual patient cohorts based on real-world or study-specific criteria. Take full control over the studied population: extend, refine and evaluate subgroups with a few clicks.
Test multiple scenarios in hours instead of months and observe drug effects without real-world constraints.
Explore drug effects across biomarkers, individuals, and entire populations with flexible granularity.
Compare simulations with clinical data and generate professional, structured reports.
What we offer
Calcium Transient
ECG Leads Grid
Integration with external results
Biomarker selection
How does our technology work?
ELEM’s technology combines patient-specific data, high-performance physics-based simulation, and advanced computational modeling to create Virtual Human Twins — scientifically validated digital replicas of human health and disease.
This enables predictive insights from individual patients to entire virtual populations, supporting faster, safer, and more data-driven biomedical advancement.
Get started
One of our experts will get in touch with you
